{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T06:00:04Z","timestamp":1773381604675,"version":"3.50.1"},"reference-count":15,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,2,9]],"date-time":"2018-02-09T00:00:00Z","timestamp":1518134400000},"content-version":"vor","delay-in-days":435,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Clinical Electrophysiology"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1016\/j.jacep.2016.07.008","type":"journal-article","created":{"date-parts":[[2016,9,15]],"date-time":"2016-09-15T23:15:31Z","timestamp":1473981331000},"page":"784-789","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"title":["Potent Inhibition of hERG Channels by the\u00a0Over-the-Counter Antidiarrheal Agent\u00a0Loperamide"],"prefix":"10.1016","volume":"2","author":[{"given":"Michael G.","family":"Klein","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark C.P.","family":"Haigney","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip S.","family":"Mehler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naheed","family":"Fatima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas P.","family":"Flagg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mori J.","family":"Krantz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacep.2016.07.008_bib1","first-page":"1897","article-title":"Torsade de pointes associated with high-dose loperamide ingestion","volume":"6","author":"Marzec","year":"2015","journal-title":"J\u00a0Innov Card Rhythm Manage"},{"key":"10.1016\/j.jacep.2016.07.008_bib2","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1124\/jpet.102.038240","article-title":"Influence of opioid agonists on cardiac human ether-a-go-go-related gene K(+) currents","volume":"303","author":"Katchman","year":"2002","journal-title":"J\u00a0Pharmacol Exp Ther"},{"key":"10.1016\/j.jacep.2016.07.008_bib3","unstructured":"Loperamide abuse\/misuse\/addiction and cardiac conduction disturbances. Available at: https:\/\/madmargaret.wordpress.com\/2014\/07\/23\/loperamide-abusemisuseaddiction-and-cardiac-conduction-disorders-article-clearinghouse-password-protected-see-comments\/. Accessed February 3,\u00a02016."},{"key":"10.1016\/j.jacep.2016.07.008_bib4","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1001\/jama.2016.1464","article-title":"CDC guideline for prescribing opioids for chronic pain\u2014United States 2016","volume":"315","author":"Dowell","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.jacep.2016.07.008_bib5","doi-asserted-by":"crossref","first-page":"387","DOI":"10.7326\/0003-4819-150-6-200903170-00103","article-title":"QTc interval screening and methadone treatment","volume":"150","author":"Krantz","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jacep.2016.07.008_bib6","unstructured":"U.S. Food and Drug Administration. Loperamide HCl (Imodium A-D) bioequivalence review. Available\u00a0at: http:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/nda\/97\/20448_IMODIUM%20A-D_BIOEQR.PDF. Accessed February 3,\u00a02016."},{"key":"10.1016\/j.jacep.2016.07.008_bib7","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/S0008-6363(02)00846-5","article-title":"Relationships between preclinical cardiac electrophysiology, clinical QT interval prolongation and torsade de pointes for a broad range of drugs: evidence for a provisional safety margin in drug development","volume":"58","author":"Redfern","year":"2002","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.jacep.2016.07.008_bib8","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.hrcr.2016.01.002","article-title":"High dose loperamide abuse associated ventricular arrhythmias","volume":"2","author":"O\u2019Connell","year":"2016","journal-title":"Heart Rhythm Case Rep"},{"key":"10.1016\/j.jacep.2016.07.008_bib9","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/1472-6750-7-93","article-title":"Improved functional expression of recombinant human ether-a-go-go (hERG) K+ channels by cultivation at reduced temperature","volume":"7","author":"Chen","year":"2007","journal-title":"BMC Biotechnol"},{"key":"10.1016\/j.jacep.2016.07.008_bib10","unstructured":"Buprenorphine, capecitabine and loperamide added to QTdrugs list. Available at: https:\/\/crediblemeds.org\/blog\/buprenorphine-capecitabine-and-loperamide-added-qtdrugs\/. Accessed May 23,\u00a02016."},{"key":"10.1016\/j.jacep.2016.07.008_bib11","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1111\/j.1476-5381.2011.01415.x","article-title":"On the relationship between block of the cardiac Na+ channel and drug-induced prolongation of the QRS complex","volume":"164","author":"Harmer","year":"2011","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.jacep.2016.07.008_bib12","doi-asserted-by":"crossref","first-page":"454","DOI":"10.3109\/15563650.2016.1159310","article-title":"Not your regular high: cardiac dysrhythmias caused by loperamide","volume":"54","author":"Wightman","year":"2016","journal-title":"Clin Toxicol (Phila)"},{"key":"10.1016\/j.jacep.2016.07.008_bib13","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1021\/mp500002y","article-title":"Multilayer spheroids to quantify drug uptake and diffusion in 3D","volume":"11","author":"Achilli","year":"2014","journal-title":"Mol Pharm"},{"key":"10.1016\/j.jacep.2016.07.008_bib14","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.drugalcdep.2012.11.003","article-title":"\u201cI just wanted to tell you that loperamide will work\u201d: a web-based study of extra-medical use of loperamide","volume":"130","author":"Daniulaityte","year":"2013","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.jacep.2016.07.008_bib15","unstructured":"Signature anti-diarrheal loperamide. Available at: http:\/\/www.amazon.com\/Kirkland-Signature-Anti-Diarrheal-Loperamide-Hydrochloride\/dp\/B002RL8FJS. Accessed May 27,\u00a02016."}],"container-title":["JACC: Clinical Electrophysiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405500X16302614?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405500X16302614?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,8]],"date-time":"2018-09-08T11:53:50Z","timestamp":1536407630000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405500X16302614"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":15,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["S2405500X16302614"],"URL":"https:\/\/doi.org\/10.1016\/j.jacep.2016.07.008","relation":{},"ISSN":["2405-500X"],"issn-type":[{"value":"2405-500X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Potent Inhibition of hERG Channels by the\u00a0Over-the-Counter Antidiarrheal Agent\u00a0Loperamide","name":"articletitle","label":"Article Title"},{"value":"JACC: Clinical Electrophysiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacep.2016.07.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 by the American College of Cardiology Foundation. Published by Elsevier.","name":"copyright","label":"Copyright"}]}}